glp 1 drugs and uti GLP-1 Induced UTIs: What Patients in Roswell, GA Need to Know How GLP-1 medications are transforming
Description
Understanding GLP-1 Drugs and Their Severe Side Effects Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications that have revolutionized the treatment of Type 2 diabetes and obesity
This sufficiently powered clinical study did not find a beneficial effect of linagliptin versus placebo on albuminuria in patients with T2DM, although exploratory analyses indicated more responders and fewer non-responders in terms of UACR in the linagliptin group
Effects of switching from liraglutide or dulaglutide to subcutaneous semaglutide on glucose metabolism and treatment satisfaction in patients with type 2 diabetes: protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)
Evidence was critically appraised following the CASP checklist
That study focused on curcumin's anti-hyperglycemic molecular mechanisms
